These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15789362)

  • 1. Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma.
    Mizutani K; Onda M; Asaka S; Akaishi J; Miyamoto S; Yoshida A; Nagahama M; Ito K; Emi M
    Cancer; 2005 May; 103(9):1785-90. PubMed ID: 15789362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    J Cancer Res Clin Oncol; 2007 Apr; 133(4):213-8. PubMed ID: 17072649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth.
    Onda M; Akaishi J; Asaka S; Okamoto J; Miyamoto S; Mizutani K; Yoshida A; Ito K; Emi M
    Br J Cancer; 2005 Jun; 92(12):2216-24. PubMed ID: 15956966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
    Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
    Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
    Hao F; Zhu Q; Lu L; Sun S; Huang Y; Zhang J; Liu Z; Miao Y; Jiao X; Chen D
    Oncol Res; 2020 Sep; 28(4):345-355. PubMed ID: 32138807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.
    Pallante P; Federico A; Berlingieri MT; Bianco M; Ferraro A; Forzati F; Iaccarino A; Russo M; Pierantoni GM; Leone V; Sacchetti S; Troncone G; Santoro M; Fusco A
    Cancer Res; 2008 Aug; 68(16):6770-8. PubMed ID: 18701502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
    Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
    Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis.
    Zhang H; Yu Y; Zhang K; Liu X; Dai Y; Jiao X
    Bioengineered; 2019 Dec; 10(1):306-315. PubMed ID: 31299871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid Follicular Cell Loss of Differentiation Induced by MicroRNA miR-17-92 Cluster Is Attenuated by CRISPR/Cas9n Gene Silencing in Anaplastic Thyroid Cancer.
    Fuziwara CS; Saito KC; Kimura ET
    Thyroid; 2020 Jan; 30(1):81-94. PubMed ID: 31578932
    [No Abstract]   [Full Text] [Related]  

  • 11. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered gene expression profiles by sodium/iodide symporter gene transfection in a human anaplastic thyroid carcinoma cell line using a radioactive complementary DNA microarray.
    Gol Choe J; Kim YR; Kim KN; Choo HJ; Shin JH; Lee YJ; Chung JK; Kim MK
    Nucl Med Commun; 2005 Dec; 26(12):1155-62. PubMed ID: 16264365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.
    Garg M; Kanojia D; Okamoto R; Jain S; Madan V; Chien W; Sampath A; Ding LW; Xuan M; Said JW; Doan NB; Liu LZ; Yang H; Gery S; Braunstein GD; Koeffler HP
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E62-72. PubMed ID: 24170107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.
    Takakura S; Mitsutake N; Nakashima M; Namba H; Saenko VA; Rogounovitch TI; Nakazawa Y; Hayashi T; Ohtsuru A; Yamashita S
    Cancer Sci; 2008 Jun; 99(6):1147-54. PubMed ID: 18429962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype.
    Salerno P; Garcia-Rostan G; Piccinin S; Bencivenga TC; Di Maro G; Doglioni C; Basolo F; Maestro R; Fusco A; Santoro M; Salvatore G
    J Clin Endocrinol Metab; 2011 May; 96(5):E772-81. PubMed ID: 21389145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
    Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
    Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.
    Aust G; Hofmann A; Laue S; Rost A; Köhler T; Scherbaum WA
    Thyroid; 1997 Oct; 7(5):713-24. PubMed ID: 9349574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of oncofetal fibronectin mRNA in thyroid anaplastic carcinoma.
    Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
    Jpn J Clin Oncol; 2007 Sep; 37(9):647-51. PubMed ID: 17704536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.
    Pacifico F; Crescenzi E; Mellone S; Iannetti A; Porrino N; Liguoro D; Moscato F; Grieco M; Formisano S; Leonardi A
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1421-30. PubMed ID: 20061417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer.
    Morrison JA; Pike LA; Sams SB; Sharma V; Zhou Q; Severson JJ; Tan AC; Wood WM; Haugen BR
    Mol Cancer; 2014 Mar; 13():62. PubMed ID: 24645981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.